As higher TRAIL levels have been reported in established MS lesions [71, 72], and affected brains show a different pattern of death receptor expression than healthy controls, the TRAIL system could play an important role in the pathological process of MS [71, 72]. This evidence concerns the gene TNFSF10 and myeloid sarcoma.